Molbio Diagnostics Ltd
- ISIN
- INE869T01028
- Instrument key
- NSE_EQ|INE869T01028
as of 21/11/2026, 5:23:54 pm
- Open
- ₹1,549.80
- Day high
- ₹1,580.00
- Day low
- ₹1,483.10
- Prev. close
- ₹1,526.40
- Volume
- 7.01 L
- VWAP
- ₹1,530.99
02/Price history
Price chart
6 months · daily candles. Hover the chart for the OHLC of any candle; the table below holds the same data row by row.
- Change · 6M
- +43.56%1,041.70 → 1,495.50
- Period high
- ₹1,686.8011/9/2026
- Period low
- ₹926.3517/8/2026
- From high
- -11.34%+61.44% from low
- Avg volume
- 25.86 L17.33 Cr total
- Volatility · ann.
- 83.1%67 candles · 28 up / 39 down
Candle data67 rows of open, high, low, close and volumeShowHide
| 20 Nov 2026 | 1,549.80 | 1,580.00 | 1,483.10 | 1,495.50 | -3.50% | 96.90 | 7.01 L |
| 19 Nov 2026 | 1,505.00 | 1,540.20 | 1,477.00 | 1,526.40 | +1.42% | 63.20 | 4.63 L |
| 18 Nov 2026 | 1,499.00 | 1,517.30 | 1,458.00 | 1,497.60 | -0.09% | 59.30 | 3.57 L |
| 17 Nov 2026 | 1,488.00 | 1,541.30 | 1,473.20 | 1,484.10 | -0.26% | 68.10 | 4.88 L |
| 16 Nov 2026 | 1,510.00 | 1,529.90 | 1,475.10 | 1,486.40 | -1.56% | 54.80 | 5.67 L |
| 13 Nov 2026 | 1,412.60 | 1,545.00 | 1,394.10 | 1,493.20 | +5.71% | 150.90 | 23.04 L |
| 12 Nov 2026 | 1,323.00 | 1,482.00 | 1,323.00 | 1,394.10 | +5.37% | 159.00 | 22.77 L |
| 11 Nov 2026 | 1,336.00 | 1,360.00 | 1,307.00 | 1,318.60 | -1.30% | 53.00 | 4.25 L |
| 9 Nov 2026 | 1,357.30 | 1,370.60 | 1,322.20 | 1,336.00 | -1.57% | 48.40 | 1.54 L |
| 8 Nov 2026 | 1,350.60 | 1,406.00 | 1,342.20 | 1,360.20 | +0.71% | 63.80 | 1.15 L |
Historical price and volume data · Showing 1–10 of 67
03/Valuation & returns
Key ratios vs sector
Company value benchmarked against the sector median. The ratio set is sector specific — banks report NIM, CASA and Net NPA instead of EV/EBITDA.
Price ÷ earnings per share
Worse than sector by 204%
Price ÷ book value per share
Worse than sector by 199%
Net income ÷ total assets
Worse than sector by 42%
Net income ÷ shareholders' equity
Worse than sector by 39%
EBIT ÷ capital employed
Worse than sector by 27%
Liquid assets ÷ current liabilities
Worse than sector by 38%
Enterprise value ÷ EBITDA
Worse than sector by 259%
04/Business
About the company
Sector: Healthcare
- ₹17,228 Cr
- $1.91B
reported in crore
reported in billion
Market capitalisation is reported at the sector-constituent level, not the standalone company level.
05/Profit & loss
Consolidated income statement
Quarterly figures in ₹ crore. Growth marked reported is provided; margins are derived.
- Revenue · Sep 2026
- ₹265 Cr-35.65% vs Jun 2026
- Net profit · Sep 2026
- ₹8 Cr-85.40% vs Jun 2026
- Operating margin
- 6.6%was 18.4%
- Revenue CAGR · 4p
- -23.1%profit -58.4% · op -50.9%
| Revenue | 265 | 411 | 565 | 581 |
|---|---|---|---|---|
| Revenue growthreported | -35.6% | -27.2% | -2.7% | — |
| Operating profit | 18 | 76 | 132 | 148 |
| Operating profit growthreported | -76.9% | -42.4% | -10.8% | — |
| Operating marginderived | 6.6% | 18.4% | 23.3% | 25.4% |
| Net profit | 8 | 53 | 96 | 107 |
| Net profit growthreported | -85.4% | -45.0% | -10.3% | — |
| Net marginderived | 2.9% | 12.8% | 16.9% | 18.4% |
| EPS — basic₹/share, annual | — | — | 14.77 | — |
Figures in ₹ crore. Margin rows are computed from the reported values.
Full annual line itemsRevenue, other income, expenses, tax, EPSShowHide
| Revenue | 1,446 | 1,020 | 837 | 332 |
|---|---|---|---|---|
| Other Income | 9 | 8 | 4 | 5 |
| Total Revenue | 1,455 | 1,028 | 841 | 337 |
| Total Expenses | 1,221 | 820 | 658 | 328 |
| Profit Before Tax | 231 | 194 | 130 | 10 |
| Tax | 67 | 56 | 46 | 13 |
| Profit After Tax | 164 | 139 | 84 | -3 |
| EPS - Basic | 14.77 | 12.87 | 9.05 | -0.06 |
| EPS - Diluted | 14.77 | 12.87 | 9.04 | -0.06 |
This breakdown is available annually, even when the summary above is quarterly. EPS rows are per share.
06/Balance sheet
Consolidated balance sheet
Only annual balance sheets are available — the quarterly filter does not apply here. Figures in ₹ crore; net worth is assets minus liabilities.
- Total assets · Mar 2026
- ₹2,148 Cr+46.99% YoY
- Total liabilities
- ₹840 Cr
- Net worth
- ₹1,309 Cr
- Liabilities ÷ assets
- 39.1%lower means a lighter balance sheet
| Total assets | 2,148 | 1,462 | 1,221 | 1,034 |
|---|---|---|---|---|
| Total liabilities | 840 | 494 | 392 | 297 |
| Net worthderived | 1,309 | 967 | 829 | 737 |
| Liabilities ÷ assetsderived | 39.1% | 33.8% | 32.1% | 28.7% |
| Asset growthderived | 47.0% | 19.7% | 18.1% | — |
Figures in ₹ crore. Stacked chart height equals total assets.
Full annual line itemsNon-current & current assets, liabilities, equity capitalShowHide
| Non-Current Assets | 764 | 532 | 398 | 423 |
|---|---|---|---|---|
| Current Assets | 1,385 | 930 | 823 | 611 |
| Total Assets | 2,148 | 1,462 | 1,221 | 1,034 |
| Current Liabilities | 557 | 442 | 343 | 258 |
| Net Current Asset | 827 | 488 | 480 | 354 |
| Non-Current Liabilities | 282 | 53 | 49 | 39 |
| Equity Capital | 1,309 | 967 | 829 | 737 |
| Total Equity & Liabilities | 2,148 | 1,462 | 1,221 | 1,034 |
Figures in ₹ crore unless the line item is per-share.
07/Cash flow
Consolidated cash flow
Annual only, in ₹ crore. Negative values are outflows, so healthy companies usually show positive operating and negative investing cash flow.
- Operating · Mar 2026
- ₹50 Cr-82.45% YoY
- Investing
- -₹93 Cr
- Financing
- ₹276 Cr
- Free cash flow
- -₹43 Croperating + investing
| Operating activities | 50 | 287 | 10 | 64 |
|---|---|---|---|---|
| Operating changereported | -82.5% | 2900.0% | -85.1% | — |
| Investing activities | -93 | -123 | -45 | -40 |
| Investing changereported | 24.0% | -172.5% | -13.3% | — |
| Financing activities | 276 | -26 | -32 | 18 |
| Financing changereported | 1155.7% | 17.1% | -273.0% | — |
| Net cash flowderived | 233 | 138 | -67 | 43 |
| Free cash flowoperating + investing | -43 | 164 | -35 | 24 |
Figures in ₹ crore.
Full annual line itemsProfit before tax through closing cash balanceShowHide
| Profit before tax | 231 | 194 | 130 | 10 |
|---|---|---|---|---|
| Income before WC changes | 353 | 285 | 273 | 47 |
| Change in Assets | -257 | -55 | -252 | 20 |
| Change in Liabilities | 25 | 137 | 32 | 35 |
| Change in WC | -232 | 82 | -220 | 55 |
| Cash flow from Operations | 50 | 287 | 10 | 64 |
| Cash flow from Investing | -93 | -123 | -45 | -40 |
| Cash flow from Financing | 276 | -26 | -32 | 18 |
| Total Cash Flow | 233 | 138 | -67 | 43 |
| Cash (Start of the year) | 63 | -75 | -8 | -51 |
| Cash (End of the year) | 336 | 63 | -75 | -8 |
Figures in ₹ crore unless the line item is per-share.
09/Events
Corporate actions
Dividends, bonuses, splits and rights issues. Filter by type, sort by any date, and expand a row for the full event detail.
No corporate actions on record
10/Comparison
Peers & competitors
Competitor set priced live. Filter by sector, sort any column, and expand a peer for its business description.
| APOLLOHOSPApollo Hospitals Enter. L | Healthcare Services | ₹9,200.00 | +5.29% | 14.13 L | ₹1,32,139 Cr | $14.68B | |
| MAXHEALTHMAX Healthcare INS Ltd | Healthcare Services | ₹1,081.00 | +3.88% | 95.32 L | ₹1,05,080 Cr | $11.68B | |
| MANIPALHOSManipal Health Enterpri L | Healthcare | ₹702.20 | +0.83% | 11.62 L | ₹92,366 Cr | $10.26B | |
| ASTERDMAster DM Quality Care Ltd | Healthcare Services | ₹779.30 | +5.41% | 26.66 L | ₹67,960 Cr | $7.55B | |
| FORTISFortis Healthcare Ltd | Healthcare Services | ₹825.00 | +1.87% | 22.88 L | ₹62,284 Cr | $6.92B | |
| MEDANTAGlobal Health Limited | Healthcare Services | ₹1,480.20 | +0.13% | 2.65 L | ₹39,829 Cr | $4.43B | |
| NHNarayana Hrudayalaya Ltd. | Healthcare Services | ₹1,945.00 | +3.84% | 7.85 L | ₹39,757 Cr | $4.42B | |
| LALPATHLABDR. LAL Path Labs Ltd. | Healthcare Services | ₹1,989.00 | +1.31% | 2.65 L | ₹33,680 Cr | $3.74B | |
| KIMSKrishna Inst Of MED SCI L | Healthcare Services | ₹795.60 | +3.62% | 10.44 L | ₹33,483 Cr | $3.72B | |
| SYNGENESyngene International Ltd | Diversified | ₹451.70 | +3.28% | 25.58 L | ₹18,240 Cr | $2.03B |
Market cap is the sector-constituent figure reported per peer · Showing 1–10 of 10
11/Coverage
Company news
Articles published in the last seven days, paginated by the provider.
No news in the last seven days
Company news is available for a rolling one-week window.